Salveen Richter analyst GOLDMAN SACHS

Currently out of the existing stock ratings of Salveen Richter, 84 are a HOLD (32.68%), 157 are a BUY (61.09%), 16 are a SELL (6.23%).

Salveen Richter

Work Performance Price Targets & Ratings Chart

Analyst Salveen Richter works at GOLDMAN SACHS with a stock forecast success ratio of 62.55% fulfilled within 248.84 days on average. Previously, Salveen Richter worked at GOLDMAN.

Salveen Richter’s has documented 518 price targets and ratings displayed on 49 stocks. The coverage is on Healthcare, Technology sectors.

Most recent stock forecast was given on AGIO, Agios Pharm at 03-May-2024.

Wall Street Analyst Salveen Richter

Analyst best performing recommendations are on NTLA (INTELLIA THERAPEUTICS).
The best stock recommendation documented was for KRTX (KARUNA THERAPEUTICS) at 11/18/2019. The price target of $109 was fulfilled within 1 day with a profit of $13 (13.54%) receiving and performance score of 135.42.

Average potential price target upside

ACAD ACADIA Pharmaceuticals ACOR Acorda Therapeutics ADPT Adaptive Biotechnologies Corp AGIO Agios Pharm ALLO Allogene Therapeutics ALNY Alnylam Pharmaceuticals BLUE Bluebird bio BMRN Biomarin Pharmaceutical BPMC Blueprint Medicines Corp CRSP Crispr Therapeutics AG DNLI Denali Therapeutics DTIL Precision BioSciences GWPH GW Pharmaceuticals plc ICPT Intercept Pharmaceuticals INCY yte KRTX Karuna Therapeutics MDGL Madrigal Pharmaceuticals MRNA Moderna MRTX Mirati Ther NTLA Intellia Therapeutics RETA Reata Pharmaceuticals SAGE Sage Therapeutic SANA Sana Biotechnology SGEN Seagen SRPT Sarepta Therapeutics TSHA Taysha Gene Therapies  VRTX Vertex Pharmaceuticals ARWR Arrowhead Pharmaceuticals ATRA Atara Biotherapeutics BIIB Biogen CNTA Centessa Pharmaceuticals PLC ADR PASG Passage Bio REGN Regeneron Pharmaceuticals RXRX Recursion Pharmaceuticals GILD Gilead Sciences RDUS Schnitzer Steel Industries AMGN Amgen QURE Uniqure NV TSVT 2Seventy Bio ADSK Autodesk FOLD Amicus Therapeutics IONS Ionis Pharmaceuticals LYEL Lyell Immunopharma ONCE Spark Therapeutics RARE Ultragenyx RCUS Arcus Biosciences SLDB Solid Biosciences LLC APLS Apellis Pharmaceuticals FDMT 4D Molecular Therapeutics 

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

22

$6.8 (44.74%)

30

16 days ago

6/7 (85.71%)

$6.75 (44.26%)

281

Buy

37

$21.8 (143.42%)

37

17 days ago

25/35 (71.43%)

$21.79 (143.26%)

486

Hold

21

$5.8 (38.16%)

39

17 days ago

7/11 (63.64%)

$5.79 (38.07%)

153

Buy

27

$11.8 (77.63%)

33

17 days ago

8/20 (40%)

$11.79 (77.51%)

119

Buy

30

$14.8 (97.37%)

36

17 days ago

0/2 (0%)

$14.79 (97.24%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Salveen Richter is most bullish on?

Potential upside of $102.05 has been obtained for VRTX (VERTEX PHARMACEUTICALS)

Which stock is Salveen Richter is most reserved on?

Potential downside of $1.5 has been obtained for AGIO (AGIOS PHARM)

What Year was the first public recommendation made by Salveen Richter?

On 2012

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?